News | January 14, 2026
ISVIR 2026 showcases cutting-edge interventional radiology in India
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
It is currently the only vaccine authorized by the Drug Controller General of India (DCGI) for active immunization against HEV in adults aged 18 to 65
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
India’s pharmaceutical sector stands at a pivotal inflection point
He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
